IP Library › Granted Patent US 9,050,443
Granted Patent B2
US 9,050,443 · App. 13/697,273 · Granted Jun 9, 2015

Wound dressing

Inventors: Esther Knill (Winterthur, CH); Regina Bruggisser (Winterthur, CH)
Assignee: IVF HARTMANN AG
A61M35/00A61F13/00063A61F13/069A61F2013/00217A61F2013/00246A61F2013/00744A61F2013/00753A61F2013/00855A61F2013/0091A61L15/46A61L2300/206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,443
App. No.
13/697,273
Granted
Jun 9, 2015
Kind
B2
Abstract

A wound dressing for wound treatment in a moist or wet milieu includes a fibrous non woven fabric-based suction-/rinsing body, a superabsorbent material distributed in the suction-/rinsing body and including negative groups, a saline aqueous solution including an antimicrobially acting substance which is cationic at pH values of 4-7.5 of the moist or wet milieu, wherein the antimicrobially acting substance is attracted and retained by the negative groups of the superabsorbent material, and is supplied to the suction-/rinsing body by the manufacturer, and a cover forming outer visible sides of the wound dressing, wherein an atraumatically acting coating is applied in some regions and in a structured manner on one of the outer visible sides which faces toward the wound, with a degree of coverage of at most 70%.

Claims (22)

1. A wound dressing for wound treatment in a moist or wet milieu, comprising:

a fibrous non woven fabric-based suction-/rinsing body;

a superabsorbent material distributed in the suction-/rinsing body and comprising negative groups;

a saline aqueous solution including an antimicrobially acting substance which is cationic at pH values of 4-7.5 of the moist or wet milieu, said antimicrobially acting substance being attracted and retained by the negative groups of the superabsorbent material, said saline aqueous solution being supplied to the suction/rinsing body by a manufacturer; and

a cover forming outer visible sides of the wound dressing, wherein an atraumatically acting coating is applied in some regions and in a structured manner on one of the outer visible sides which faces toward the wound, with a degree of coverage of at most 70%, wherein a distance of neighboring coated surface areas to each other is at least 1 mm and at most 5 mm.

2. The wound dressing of claim 1 , wherein the saline aqueous solution is supplied to the suction/rinsing body to a point of saturation.

3. The wound dressing of claim 1 , wherein the saline aqueous solution is Ringer's solution.

4. The wound dressing of claim 1 , further comprising an evaporation-inhibiting film layer provided on a side of the suction/rinsing body which faces away from the wound.

5. The wound dressing of claim 4 , wherein another side of the cover which faces away from the wound is provided with a non woven fabric, and wherein a film layer which is laminated on an outside of the non woven fabric, said film layer forming the evaporation-inhibiting film layer.

6. The wound dressing of claim 5 , wherein the non woven fabric is a polyolefin-non woven fabric.

7. The wound dressing of claim 1 , wherein the antimicrobially acting substance is a biguanide.

8. The wound dressing of claim 1 , wherein a concentration of the antimicrobially acting substance in the saline aqueous solution is 0.06-0.20 weight %.

9. The wound dressing of claim 1 , wherein a release of the antimicrobially acting substance from the wound dressing is visually undetectable in a zone of inhibition test.

10. The wound dressing of claim 1 , wherein the cover on the side of the wound dressing which faces toward the wound and/or on the side of the wound dressing which faces away from the wound is formed by a textile flat material.

11. The wound dressing of claim 1 , wherein the atraumatically acting coating is a silicone coating.

12. The wound dressing of claim 1 , wherein the degree of coverage of the atraumatically acting coating ( 16 ) is 40-70%.

13. The wound dressing of claim 1 , wherein the atraumatically acting coating forms an overhang (in Z-direction) over a plane of the outside of the cover of 0.03-0.5 mm.

14. The wound dressing of claim 1 , wherein the atraumatically acting coating has a dimension in at least one planar direction of at most 4 mm.

15. The wound dressing of claim 1 , wherein the suction-/rinsing body includes cellulosic fibers and thermosetting fibers.

16. The wound dressing of claim 1 , wherein a surface specific evaporation rate in a time interval 24 h to 72 h after a simulated application of the wound dressing is <0.020 g/24 h cm 2 .

17. The wound dressing of claim 1 , wherein the surface specific evaporation rate within 24 h after the simulated placement of the wound dressing is <0.050 g/24 h cm 2 liquid.

18. The wound dressing of claim 1 , having a dimension in at least one planar direction of 2-30 cm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2012
From: KNILL, ESTHER; BRUGGISSER, REGINA
To: IVF HARTMANN AG
Reel/Frame 029527/0254 →
Priority Claims (1)
DE 10 2010 020 050 · May 11, 2010 · national
Continuity (1)
Related Publication 20140163485A1 · Jun 12, 2014